Abstract:Abstract Clear cell renal cell carcinoma (ccRCC) is the most common type of renal cancer (RCC). The increasing incidence and poor prognosis of ccRCC after tumour metastasis makes the study of its pathogenesis extremely important. Traditional studies mostly focus on the regulation of ccRCC by single gene, while ignoring the impact of tumour heterogeneity on disease progression. The purpose of this study is to construct a prognostic risk model for ccRCC by analysing the differential marker genes related to immune cells in the single-cell database for providing help in clinical diagnosis and targeted therapy. Single-cell data and ligand-receptor relationship pair data were downloaded from related publications, and ccRCC phenotype and expression profile data were downloaded from TCGA and CPTAC. The DEGs and marker genes of the immune cell were combined and then intersected with the ligand-receptor gene data, and the 981 ligand-receptor relationship pairs obtained were intersected with the target gene of the transcription factor afterwards; 7,987 immune cell multilayer network relationship pairs were finally observed. Then, the genes in the network and the genes in TCGA were intersected to obtain 966 genes for constructing a co-expression network. Subsequently, 53 genes in black and magenta modules related to prognosis were screened by WGCNA for subsequent analysis. Whereafter, using the data of TCGA, 28 genes with significant prognostic differences were screened out through univariate Cox regression analysis. After that, LASSO regression analysis of these genes was performed to obtain a prognostic risk scoring model containing 16 genes, and CPTAC data showed that the effectiveness of this model was good. The results of correlation analysis between the risk score and other clinical factors showed that age, grade, M, T, stage and risk score were all significantly different (p < 0.05), and the results of prognostic accuracy also reached the threshold of qualification. Combined with clinical information, univariate and multivariate Cox regression analyses verified that risk score was an independent prognostic factor (p < 0.05). A nomogram constructed based on a predictive model for predicting the overall survival was established, and internal validation performed well. Our findings suggest that the predictive model built based on the immune cells scRNA-seq will enable us to judge the prognosis of patients with ccRCC and provide more accurate directions for basic relevant research and clinical practice.

Comprehensive Transcriptomic Analysis of Critical RNA Regulation Associated With Metabolism and Prognosis in Clear Cell Renal Carcinoma

A five-gene methylation signature predicts overall survival of patients with clear cell renal cell carcinoma

A cluster of metabolism-related genes predict prognosis and progression of clear cell renal cell carcinoma

A Cerna Network Composed of Survival-Related Lncrnas, Mirnas, and Mrnas in Clear Cell Renal Carcinoma.

[Comprehensive Analysis of the Aberrantly Expressed Profiles of Lncrnas, Mirnas and the Regulation Network of the Associated Cernas in Clear Cell Renal Cell Carcinoma].

Comprehensive analysis of RNA sequencing and integrated machine learning reveals a metabolism related prognostic signature for improving outcomes in ccRCC

A prognostic nomogram based on competing endogenous RNA network for clear-cell renal cell carcinoma

Identification of Prognosis- and Metastasis-related Enhancer RNAs in Renal Cell Carcinoma

A novel lipid metabolism gene signature for clear cell renal cell carcinoma using integrated bioinformatics analysis

An optimal prognostic model based on gene expression for clear cell renal cell carcinoma

Bioinformatic Identification of Key Genes and Analysis of Prognostic Values in Clear Cell Renal Cell Carcinoma.

Development and Validation of a Combined Hypoxia- and Metabolism-Related Prognostic Signature to Predict Clinical Prognosis and Immunotherapy Responses in Clear Cell Renal Cell Carcinoma

Screening and Identification of Novel Promoter Signatures in Clear Cell Renal Cell Carcinoma Metastasis.

Construction and Comprehensive Analysis of Dysregulated Long Non-Coding RNA-associated Competing Endogenous RNA Network in Clear Cell Renal Cell Carcinoma

Identification of Potential Novel Differentially-Expressed Genes and Their Role in Invasion and Migration in Renal Cell Carcinoma.

Identification of Prognostic Biomarkers for Clear Cell Renal Cell Carcinoma (ccrcc) by Transcriptomics.

A Metastasis-Related lncRNA Signature Correlates With the Prognosis in Clear Cell Renal Cell Carcinoma

Metabolic Reprogramming of Cancer Stem Cells and a Novel Eight-Gene Metabolism-Related Risk Signature in Clear Cell Renal Carcinoma

Integrated analysis of single-cell and transcriptome based RNA-seq multilayer network and WGCNA for construction and validation of an immune cell-related prognostic model in clear cell renal cell carcinoma

A novel amino acid metabolism-related gene risk signature for predicting prognosis in clear cell renal cell carcinoma

Establishing a Prognostic Model Based on Five Starvation-Related Long Non-Coding RNAs for Clear Cell Renal Cell Carcinoma.